These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

638 related items for PubMed ID: 25744335

  • 1. Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration.
    Shin JY, Choi M, Chung B, Byeon SH.
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2151-60. PubMed ID: 25744335
    [Abstract] [Full Text] [Related]

  • 2. RETINAL PIGMENT EPITHELIAL TEAR AFTER INTRAVITREAL RANIBIZUMAB TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Cho HJ, Kim HS, Yoo SG, Han JI, Lew YJ, Cho SW, Lee TG, Kim JW.
    Retina; 2016 Oct; 36(10):1851-9. PubMed ID: 27074658
    [Abstract] [Full Text] [Related]

  • 3. RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis.
    Heimes B, Farecki ML, Bartels S, Barrelmann A, Gutfleisch M, Spital G, Lommatzsch A, Pauleikhoff D.
    Retina; 2016 May; 36(5):868-74. PubMed ID: 26655607
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography.
    Nagiel A, Freund KB, Spaide RF, Munch IC, Larsen M, Sarraf D.
    Am J Ophthalmol; 2013 Nov; 156(5):981-988.e2. PubMed ID: 23972309
    [Abstract] [Full Text] [Related]

  • 5. Differentiating Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy Using OCT B-Scan.
    Kokame GT, Omizo JN, Kokame KA, Yamane ML.
    Ophthalmol Retina; 2021 Oct; 5(10):954-961. PubMed ID: 34022443
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The factors associated with retinal pigment epithelium tear development in the early phase after treatment initiation for age-related macular degeneration.
    Shiose S, Notomi S, Hashimoto S, Nagata J, Fukuda Y, Kano K, Ishikawa K, Sonoda KH.
    Graefes Arch Clin Exp Ophthalmol; 2024 Oct; 262(10):3171-3180. PubMed ID: 38713397
    [Abstract] [Full Text] [Related]

  • 11. DOUBLE RETINAL PIGMENT EPITHELIUM TEARS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Mouallem A, Sarraf D, Chen X, Capuano V, Souied EH, Querques G.
    Retina; 2016 Nov; 36(11):2197-2204. PubMed ID: 27145251
    [Abstract] [Full Text] [Related]

  • 12. THE OCCURRENCE, CHARACTERISTICS, MANAGEMENT, AND PROGNOSIS OF RETINAL PIGMENT EPITHELIUM TEARS IN PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY: A Retrospective Study of 397 Patients.
    Zhao XY, Xia S, Luo MY, Wang EQ, Chen YX.
    Retina; 2020 Mar; 40(3):477-489. PubMed ID: 30475788
    [Abstract] [Full Text] [Related]

  • 13. Response of vascular pigment epithelium detachment due to age-related macular degeneration to monthly treatment with ranibizumab: the prospective, multicentre RECOVER study.
    Clemens CR, Wolf A, Alten F, Milojcic C, Heiduschka P, Eter N.
    Acta Ophthalmol; 2017 Nov; 95(7):683-689. PubMed ID: 28084038
    [Abstract] [Full Text] [Related]

  • 14. Prediction of retinal pigment epithelial tear in serous vascularized pigment epithelium detachment.
    Clemens CR, Bastian N, Alten F, Milojcic C, Heiduschka P, Eter N.
    Acta Ophthalmol; 2014 Feb; 92(1):e50-6. PubMed ID: 23819839
    [Abstract] [Full Text] [Related]

  • 15. Influence of submacular hemorrhage at baseline on the long-term outcomes of aflibercept treatment for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
    Hosokawa MM, Ouchi C, Shiode Y, Kimura S, Matoba R, Morita T, Morizane Y.
    Graefes Arch Clin Exp Ophthalmol; 2024 Oct; 262(10):3099-3107. PubMed ID: 38625447
    [Abstract] [Full Text] [Related]

  • 16. Retinal Pigment Epithelial Atrophy in Neovascular Age-Related Macular Degeneration After Ranibizumab Treatment.
    Kuroda Y, Yamashiro K, Tsujikawa A, Ooto S, Tamura H, Oishi A, Nakanishi H, Miyake M, Yoshikawa M, Yoshimura N.
    Am J Ophthalmol; 2016 Jan; 161():94-103.e1. PubMed ID: 26432927
    [Abstract] [Full Text] [Related]

  • 17. Incidence of retinal pigment epithelial tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration.
    Cunningham ET, Feiner L, Chung C, Tuomi L, Ehrlich JS.
    Ophthalmology; 2011 Dec; 118(12):2447-52. PubMed ID: 21872935
    [Abstract] [Full Text] [Related]

  • 18. Prospective evaluation of the incidence and risk factors for the development of RPE tears after high- and low-dose ranibizumab therapy.
    Sarraf D, Chan C, Rahimy E, Abraham P.
    Retina; 2013 Sep; 33(8):1551-7. PubMed ID: 23652578
    [Abstract] [Full Text] [Related]

  • 19. Sequential retinal pigment epithelium tears following intravitreal Ranibizumab injections for age-related macular degeneration.
    Venkatesh R, Agrawal R, Thomas S, Reddy NG, Gupta A, Yadav NK, Chhablani J.
    Eur J Ophthalmol; 2023 May; 33(3):NP100-NP104. PubMed ID: 35388732
    [Abstract] [Full Text] [Related]

  • 20. RPE tears after pegaptanib treatment in age-related macular degeneration.
    Chang LK, Flaxel CJ, Lauer AK, Sarraf D.
    Retina; 2007 Sep; 27(7):857-63. PubMed ID: 17891009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.